Amalgamated Bank Mirati Therapeutics, Inc. Transaction History

Amalgamated Bank

$11.7 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$41.99 - $62.38 $29,351 - $43,603	699 Added 10.26%	7,512 $441,000
Q3 2023 Nov 08, 2023	SELL	$27.8 - $45.35 $500 - $816	-18 Reduced 0.26%	6,813 $297,000
Q2 2023 Aug 11, 2023	SELL	$36.13 - $49.49 $10,875 - $14,896	-301 Reduced 4.22%	6,831 $246,000
Q1 2023 May 02, 2023	SELL	$36.54 - $54.26 $39,061 - $58,003	-1,069 Reduced 13.03%	7,132 $265,000
Q4 2022 Feb 10, 2023	BUY	$41.27 - $98.62 $15,228 - $36,390	369 Added 4.71%	8,201 $372,000
Q3 2022 Nov 09, 2022	BUY	$59.5 - $86.7 $4,641 - $6,762	78 Added 1.01%	7,832 $547,000
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $60,228 - $136,435	-1,538 Reduced 16.55%	7,754 $521,000
Q1 2022 Jun 30, 2022	BUY	$75.82 - $150.97 $56,258 - $112,019	742 Added 8.68%	9,292 $764,000
Q4 2021 Feb 15, 2022	BUY	$132.01 - $190.29 $189,962 - $273,827	1,439 Added 20.24%	8,550 $1.25 Million
Q3 2021 Oct 29, 2021	SELL	$132.13 - $177.45 $55,758 - $74,883	-422 Reduced 5.6%	7,111 $1.26 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $207,648 - $259,170	1,442 Added 23.67%	7,533 $1.22 Million
Q1 2021 May 13, 2021	SELL	$158.92 - $221.61 $93,286 - $130,085	-587 Reduced 8.79%	6,091 $1.04 Million
Q4 2020 Feb 12, 2021	BUY	$162.05 - $240.27 $136,608 - $202,547	843 Added 14.45%	6,678 $1.47 Million
Q3 2020 Oct 30, 2020	SELL	$113.26 - $167.27 $5,436 - $8,028	-48 Reduced 0.82%	5,835 $969,000
Q2 2020 Aug 10, 2020	BUY	$72.01 - $120.39 $56,311 - $94,144	782 Added 15.33%	5,883 $672,000
Q1 2020 May 13, 2020	BUY	$69.78 - $116.21 $14,374 - $23,939	206 Added 4.21%	5,101 $392,000
Q4 2019 Feb 13, 2020	BUY	$70.76 - $128.86 $33,469 - $60,950	473 Added 10.7%	4,895 $631,000
Q3 2019 Nov 13, 2019	SELL	$77.91 - $109.6 $4,674 - $6,576	-60 Reduced 1.34%	4,422 $345,000
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $74,065 - $130,363	1,245 Added 38.46%	4,482 $462,000
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $141,295 - $255,561	3,237 New	3,237 $237,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account